# Monitoring Exhaled Propofol to Individualize General Anesthesia

> **NCT01191021** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 20 (actual)

## Conditions studied

- General Anesthesia

## Interventions

- **DRUG:** Propofol Anesthesia

## Key facts

- **NCT ID:** NCT01191021
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01191021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01191021, "Monitoring Exhaled Propofol to Individualize General Anesthesia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01191021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*